A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1997
11/06/1997	CA2252762A1 Methods and compounds for curing diseases caused by mutations
11/06/1997	CA2252723A1 1-methylcarbapenem derivatives
11/06/1997	CA2252706A1 Polypeptide conjugates for transporting substances across cell membranes
11/06/1997	CA2252696A1 Azetidinone derivatives for the treatment of atherosclerosis
11/06/1997	CA2252675A1 Methods for selecting and producing t cell peptide epitopes and vaccines incorporating said selected epitopes
11/06/1997	CA2252542A1 Dna, rna and a protein useful for detection of a mycobacterial infection
11/06/1997	CA2252492A1 Acyl urea compounds for the treatment of coccidioidomycosis in warm-blooded animals
11/06/1997	CA2252455A1 Molecules comprising an impdh-like binding pocket and encoded data storage medium capable of graphically displaying them
11/06/1997	CA2252432A1 Mammalian mixed lymphocyte receptors, chemokine receptors [mmlr-ccr]
11/06/1997	CA2251813A1 5,6,7,8-tetrahydropyrido¬2,3-d\|pyrimidines
11/06/1997	CA2250759A1 A cytoplasmic gene expression system which utilizes a prokaryotic rna polymerase autogene
11/06/1997	CA2232682A1 Use of prolactin as a tgf-beta antagonist
11/06/1997	CA2230866A1 Human p2x4 receptor splice-variants
11/06/1997	CA2203234A1 Feline vaccines containing chlamydia psittaci and method for making the same
11/05/1997	EP0805158A2 Halo-substituted protein kinase C inhibitors
11/05/1997	EP0805156A1 8-alkoxyquinolonecarboxylic acid hydrate with excellent stability and process for producing the same
11/05/1997	EP0805154A1 N,n-disubstituted amic acid derivative
11/05/1997	EP0805153A1 Novel muscarinic receptor agonists
11/05/1997	EP0805147A1 Novel N-substituted alpha aminoacid amides as calcium channel modulators
11/05/1997	EP0804927A1 Multi-antioxidant medicament
11/05/1997	EP0804926A1 Combined preparation for treating male hypogonadism and men with hypophysal disorders
11/05/1997	EP0804922A1 Photostable screening composition containing a derivative of dibenzoylmethane and an alkyletherpolysaccharide
11/05/1997	EP0804876A1 Iodine/resin disinfectant and a procedure for the preparation thereof
11/05/1997	EP0804615A1 Apolipoprotein e polymorphism and treatment of alzheimer's disease
11/05/1997	EP0804613A1 Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins
11/05/1997	EP0804585A1 Capl-specific oligonucleotides and methods of inhibiting metastatic cancer
11/05/1997	EP0804578A1 Il-2r-associated polypeptide and dna molecules coding therefor
11/05/1997	EP0804576A1 A novel haemopoietin receptor
11/05/1997	EP0804574A1 Human kappa opioid receptor, nucleic acids and uses thereof
11/05/1997	EP0804487A2 Bispecific antigen-binding molecules
11/05/1997	EP0804464A1 Aromatic heterocyclic derivatives as enzyme inhibitors
11/05/1997	EP0804459A1 Therapeutic compound - fatty acid conjugates
11/05/1997	EP0804456A1 Peptide nucleic acid conjugates
11/05/1997	EP0804453A1 Method for detection and treatment of breast cancer
11/05/1997	EP0804447A1 Procedures for obtaining ribo-c-nucleosides
11/05/1997	EP0804445A1 Metallocenic diarylethylene derivatives, methods for their preparation and pharmaceutical compositions containing same
11/05/1997	EP0804442A1 NEW THIAZOLO 3,2-a]QUINOLINE AND THIAZOLO 3,2-a]NAPHTHYRIDINE DERIVATIVES
11/05/1997	EP0804440A1 Tricyclic benzazepine vasopressin antagonists
11/05/1997	EP0804439A1 Beta, beta '-dihydroxy meso-substituted chlorins, isobacteriochlorins, bacteriochlorins, and methods for making the same from beta ,beta '-unsubstituted tetrapyrrolic macrocycles
11/05/1997	EP0804438A1 Tricyclic benzazepine vasopressin antagonists
11/05/1997	EP0804437A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USES THEREOF
11/05/1997	EP0804436A1 Guanine derivative
11/05/1997	EP0804435A1 Novel imidazole derivatives, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same
11/05/1997	EP0804434A1 Azetidine, pyrrolidine and piperidine derivatives
11/05/1997	EP0804433A1 Indole derivative for the treatment of migraine
11/05/1997	EP0804431A1 GLYCOPROTEIN IIb/IIIa ANTAGONISTS
11/05/1997	EP0804430A1 Synthesis of optically pure 4-alkenyl- or 4-alkanyl-2-hydroxytetronic acids
11/05/1997	EP0804428A1 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
11/05/1997	EP0804427A1 Lta4 hydrolase inhibitors
11/05/1997	EP0804425A2 Benzodiazepine derivatives
11/05/1997	EP0804420A1 Tricyclic benzazepine vasopressin antagonists
11/05/1997	EP0804419A1 Quinoline derivatives as tachykinin nk 3 receptor antagonists
11/05/1997	EP0804418A2 Platelet aggregation inhibitors
11/05/1997	EP0804416A1 Heterocyclic compounds, useful as allosteric effectors at muscarinic receptors
11/05/1997	EP0804415A1 Novel farnesyl transferase inhibitors, preparation thereof and pharmaceutical compositions containing same
11/05/1997	EP0804414A1 Complementary dna and toxins
11/05/1997	EP0804413A1 Nitrogen mustard prodrugs with novel lipophilic protecting groups, and processes for their production
11/05/1997	EP0804411A1 Synthetic polyunsaturated fatty acid analogues
11/05/1997	EP0804283A1 Aqueous solvent encapsulation method, apparatus and microcapsules
11/05/1997	EP0804247A1 Selenium conjugates for the preparation of free radical pharmaceuticals
11/05/1997	EP0804242A1 The use of dimeticone as a transport and carrier system and/or drug delivery system
11/05/1997	EP0804240A1 Compounds for preventing multidrug resistance in cancer cells containing protein kinase inhibitors
11/05/1997	EP0804239A1 Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof
11/05/1997	EP0804229A2 Composition containing amlodipine, or a salt or felodipine and anace inhibitor
11/05/1997	EP0804220A1 Pharmaceutical formulations comprising a salt of clavulanic acid, vancomycin and one or more beta-lactam antibiotics
11/05/1997	EP0804216A1 Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
11/05/1997	EP0804214A1 Growth differentiation factor-6
11/05/1997	EP0804209A1 Chemical castration
11/05/1997	EP0804208A1 Effervescent composition containing iodinated polyvinylpyrrolidone, and use thereof for disinfection
11/05/1997	EP0804207A1 Enteral formulations for the treatment of inflammation and infection containing a saponin, possibly in combination with other compounds
11/05/1997	EP0804206A1 Antifungal agent containing crotamiton, and salicyclic aldehyde
11/05/1997	EP0804205A1 4-aza-19-norandrostane derivatives
11/05/1997	EP0804204A1 Treatment of medical disorders associated with free radical formation
11/05/1997	EP0804203A1 Rectal flunisolide compositions for treating inflammatory intestinal disorders
11/05/1997	EP0804202A1 Estrogens and parathyroid hormone for treating osteoporosis
11/05/1997	EP0804201A1 Method of treating opportunistic infections with azaspiranes
11/05/1997	EP0804200A1 A method of treating chemical dependency in mammals and a composition therefor
11/05/1997	EP0804199A1 Use of penciclorin for the treatment of post-therapeutic neuralgia
11/05/1997	EP0804198A1 An exercise hydration regimen to enhance exercise endurance and performance
11/05/1997	EP0804197A1 Crystalline trimetrexate salts and the process for making the same
11/05/1997	EP0804196A1 Use of serotonin antagonists (5ht 3?) for treating fibromyalgia
11/05/1997	EP0804195A2 Depolarizing skeletal muscle relaxants
11/05/1997	EP0804194A1 Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists
11/05/1997	EP0804193A1 Thiazolidine derivatives for the treatment of psoriasis
11/05/1997	EP0804192A1 Pharmaceutical preparations for tumour necrosis factor (tnf) inhibition
11/05/1997	EP0804191A1 Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor
11/05/1997	EP0804190A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of gynaecological disorders
11/05/1997	EP0804189A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative treatment
11/05/1997	EP0804188A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis
11/05/1997	EP0804187A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity
11/05/1997	EP0804186A1 Indole diterpene alkaloid compounds
11/05/1997	EP0804185A1 Arsenic medicaments for the treatment of chronic fatigue syndrome
11/05/1997	EP0804184A1 USE OF $g(v)-GUANIDINOCARBOXYLIC ACID ESTERS
11/05/1997	EP0804183A1 Use of creatine or creatine analogs for the treatment of diseases of the nervous system
11/05/1997	EP0804182A2 Use of gabapentin in the treatment of anxiety and panic
11/05/1997	EP0804181A1 Method and composition for treating mammalian diseases caused by inflammatory response
11/05/1997	EP0804180A1 Method of inhibiting cathepsin k
11/05/1997	EP0804179A2 Use of n-acyl derivatives of aminoalcohols in the manufacture of a medicament for practising neuroprotective action in neuropathological states connected with excitotoxicity
11/05/1997	EP0804178A1 A gelatine capsule containing selegiline or derivative and paraffin as carrier
11/05/1997	EP0804177A1 Use of nitric oxide-releasing agents for reducing metastasis risk

1 ... 6728 6729 6730 6731 6732 6733 6734 6735 6736 6737 6738 6739 6740 6741 6742 6743 6744 6745 6746 6747 6748 ... 7860